BackAbCellera Biologics Overview

AbCellera Biologics Net Tangible Assets

AbCellera Biologics's net tangible assets is $940M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$938.08M

Peer average

Loading

AbCellera Biologics Net Tangible Assets History

Loading

AbCellera Biologics vs. peers: Net Tangible Assets Comparison

Loading

AbCellera Biologics Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AbCellera Biologics (ABCL) FAQ

AbCellera Biologics's net tangible assets stands at $940M as of March 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

AbCellera Biologics reported $940M in net tangible assets versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in net tangible assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how AbCellera Biologics's net tangible assets evolved across reporting periods, while the comparison chart places ABCL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.